Mesenchymal stromal cells (MSCs) are multipotent cells found in several adult tissues; they have the capacity to differentiate into mesodermal, ectodermal, and endodermal tissues in vitro. There have been several reports that MSCs have therapeutic effects in a variety of diseases. Therefore, using a cell labeling technique, monitoring their temporal and spatial migration in vivo, would be useful in the clinical setting. Magnetic resonance imaging (MRI)-tracking of superparamagnetic iron oxide (SPIO)-labeled cells-is a noninvasive technique for determining the location and migration of transplanted cells. In the present study, we evaluated the influence and toxicity of SPIO (ferumoxides) labeling on multiple differentiated MSCs. To evaluate the influence and toxicity of ferumoxides labeling on differentiation of MSCs, a variety of concentrations of ferumoxides were used for labeling MSCs. We found that the cytoplasm of adherent cells was effectively labeled at low concentrations of ferumoxides. Compared with unlabeled controls, the ferumoxides-labeled MSCs exhibited a similar proliferation rate and apoptotic progression. The labeled MSCs differentiated into osteoblasts and adipocytes in an identical fashion as the unlabeled cells. However, chondrogenesis and neurogenesis were inhibited at high concentrations of ferumoxides. Our results suggest the effective concentration for ferumoxides use in tracking MSCs.
INTRODUCTION
adult tissues, and have the capacity to differentiate in vitro into several mesodermal tissues (bone, cartilage, tendon, muscle, and adipose) and endodermal tissue (he-Currently, intensive research evaluating stem cells for their therapeutic potential is under way worldwide. Al-patocyte) as well as ectodermal tissue (neurons) (28) . Moreover, MSCs are not immunogenic; they do not though using embryonic-and fetal-derived stem cells may be a viable approach for developing new treatment elicit a proliferative response of allogeneic lymphocytes in vitro (19) . These characteristics make MSCs potent for incurable diseases (23,25), ethical and moral concerns, as well as the limited availability of stems cells, candidates for the development of cell-based therapeutic strategies. The therapeutic effects of MSCs have re-have prompted the search for alternative stem cell sources. Human umbilical cord blood (hUCB) is con-cently been reported for bone, joint, and neuronal diseases (22, 26) . Improving the therapeutic potency and ventionally used as an alternative source of stem or stromal cells, hematopoietic stem cells, and MSCs (5, 7) . sensitivity of MSC treatment as well as developing a noninvasive technique for tracking MSCs following More than 3,000 cases of hUCB transplantation have been performed worldwide for patients suffering from a transplantation is needed. Among the available methods for tracking cells, mag-variety of hematologic and genetic disorders (6, 13, 15, 17, 18, 24) . MSCs are multipotent cells found in several netic resonance imaging (MRI) of in vivo MSCs labeled with superparamagnetic iron oxide (SPIO) nanoparticles days. Neuronal differentiation was induced by neurogenic medium that was composed of DMEM/F12 me-is a powerful technique for monitoring the behavior of these cells. Ferumoxides is a dextran-coated SPIO ap-dium supplemented with 200 µM butylated hydroxyanisole, 25 µg/ml insulin (Sigma), 25 mM KCl, 2 µM proved by the US Food and Drug Administration (US FDA) as an MRI contrast agent; it has been shown to valproic acid (Sigma), 10 µM forskolin (Sigma), and 1 µM hydrocortisone (Sigma). be an effective and efficient labeling agent for stem cells and other mammalian cells (10, 11) .
RT-PCR Analysis In this study, we provide data for the first time that
The mRNA expression levels of the chondrogenic shows that ferumoxides can be used to label hUCB proteins and neurogenic proteins were compared at MSCs. In addition, we demonstrate that high concentrasteady state in the ferumoxides-unlabeled and -labeled tion of ferumoxides can prevent MSCs from differentiat-hUCB MSCs by performing RT-PCR. The total RNA ing into chondrocytes and neurons.
was extracted from each differentiated cell by the modi-MATERIALS AND METHODS fied method of Chomczynski and Sacchi (9) . The sense primer for NF-M was 5′-TGGGAAATGGCTCGTC hUCB MSCs ATTT-3′ and the reverse primer was 5′-CTTCATG The hUCB samples were obtained with consent of GAAGCGGC CAATT-3′. The sense primer for MAP2 the mothers. The hUCB MSCs were separated and mainwas 5′-CCTTTTTACAGCCAGATGAC-3′ and the retained following the previously described methods (28) .
verse primer was 5′-GTGAAAGTATCCCTTTGCTG-3′. hUCB MSCs were cultured with ferumoxides (Feridex The primers for chondrogenic proteins and GAPDH as I.V., Taejoon, Seoul, Korea) in culture media. After 72 well as methods for PCR were previously reported (28) . h, the MSCs were washed three times to remove the excess ferumoxides. The labeled cells were incubated Western Blotting for 30 min with 2% potassium ferrocyanide [Perl re-Cell extract protein (10 µg) was used to conduct elecagent for Prussian blue (PB) staining] (Sigma, St. Louis, trophoresis on 4-20% denatured PAGE gels (Bio-Rad MO, USA) in 1% hydrochloric acid, washed, and coun-Laboratories) and then Western blotting was done as terstained with nuclear fast red (Sigma) to confirm the previously described (20) . Mouse anti-human tubulin βuptake of ferumoxides into the cytoplasm. III (TBIII) monoclonal antibody (mAb) (Sigma) and mouse anti-human neuronal nuclei (NeuN) mAb were Immunophenotyping of hUCB MSCs used as a first antibody. The protein bands were detected To analyze the cell surface expression of typical by chemiluminescence (Amersham Pharmacia, Biotech, marker proteins, hUCB MSCs at the fifth passage were NJ, USA). labeled with the following anti-human antibodies: CD45-FITC, CD34-FITC, CD14-FITC, HLA-DR-FITC (Bec-Cell Death Assays ton Dickinson, San Jose, CA, USA), CD29-PE, CD44-To determine if ferumoxides labeling resulted in PE, CD73-PE, CD90-PE, CD166-PE, HLA-AB-PE changes in the rates of apoptosis, both unlabeled and (Pharmingen, Los Angeles, CA, USA), and CD105-PE labeled cells were collected after 72 h, washed twice (Serotec, NC, USA). Mouse isotype antibodies served with ice-cold phosphate-buffered saline (PBS), and then as the respective controls (Becton Dickinson). Ten thouresuspended in 1 ml of annexin media (Vybrant apoptosand cells were measured using a FACScan flow cytosis assay kit, Molecular Probes, OR, USA) at 1 × 10 6 meter (Becton Dickinson) and the results were analyzed cells/ml. Ten microliters of FITC-labeled annexin V and by CellQuest software (Becton Dickinson).
2 µl propidium iodide solution were added to 100 µl of cell suspension; this was then kept at room temperature Multilineage Differentiation for 15-20 min, and next flow cytometry was performed Ferumoxides-labeled MSCs were induced to osteogeusing a fluorescent-activated cell sorter (FACScalibur, nic, adipogenic, and chondrogenic differentiation accord-Becton Dickinson). The dead cells were identified by ing to a previous study (28) to see whether the labeling trypan blue exclusion staining. ferumoxides had any adverse effect on their multilineage differentiation.
RESULTS

Immunophenotyping of the hUCB MSCs Neurogenic Differentiation
Poly-D-lysine and laminin (Sigma)-coated plate was The expression of MSC-related cell surface antigens was evaluated on four hUCB MSCs at the fifth passage used to induce neuronal differentiation. Prior to neuronal induction, the hUCB MSCs were pretreated in DMEM, by flow cytometry (Fig. 1 ). Similar to MSCs from bone marrow (4), all hUCB MSCs were strongly positive for 10% FBS, and 20 ng/ml basic fibroblast growth factor (R&D Systems, Inc., Minneapolis, MN, USA) for 2 MSC-related antigens: CD73 (98.7 ± 1.1%), CD105 (98.3 ± 1.2%), CD90 (94.4 ± 8.7%), CD166 (98.3 ± peared to be unaffected by ferumoxides because both the labeled and unlabeled MSC cultures grew in a simi-1.26%), CD29 (97.1 ± 3.5%), and CD44 (98.2 ± 1.0%). In addition, these cells were stained positively for HLA lar fashion as noted by the confluent monolayers. At harvest, trypan blue dye exclusion assay indicated that class I (HLA-AB; 97.8 ± 2.6) and negatively for HLA class II (HLA-DR). However, the hUCB MSCs did not cell viabilities, of the MSCs, were not changed by ferumoxides labeling [labeled (92-94%) and nonlabeled express the hematopoietic markers: CD14, CD34, and CD45. Among the four hUCB MSCs, we selected one (95%)] at different points in time (24 and 72 h, respectively) ( Fig. 2B) . Similarly, there were no significant hUCB MSC depending on the capacity for differentiation in each lineage.
differences between the labeled and unlabeled hUCB MSC cells in the rate of apoptosis (Fig. 2C ).
Cytotoxic Effect of Ferumoxides
Osteogenic and Adipogenic Differentiation Incubation of the hUCB MSCs with ferumoxides for of Furoximide-Labeled hUCB MSCs 72 h showed detectable PB staining that was dependent on the concentration of ferumoxides ( Fig. 2A ). Labeling
To evaluate the influence of ferumoxides labeling on multilineage differentiation, hUCB MSCs were incu-efficacy was reproducible at approximately 90-100% of hUCB MSCs. The in vitro culture of hUCB MSCs ap-bated with ferumoxides for 72 h to induce osteogenic and adipogenic differentiation. Both the labeled and un-drogenic differentiation was interfered with after ferumoxides labeling. On the basis of the Safranin-O stain-labeled MSCs showed similar differentiation into the osteogenic and adipogenic lineages when grown in culture ing, incubation of hUCB MSCs for 72 h with 50-100 µg/ml of ferumoxides provides optimum conditions for with the appropriate differentiation medium. Osteogenic differentiation was determined by von Kossa's and ALP cell labeling, with no prevention of chondrocyte differentiation compared to unlabeled controls. However, fer-staining ( Fig. 3B and C). Adipogenic differentiation was apparent in the unlabeled and labeled hUCB MSCs by umoxides labeling at a high concentration (200 µg/ml) induced abnormal shape of chondrocyte-like lacunae. cellular accumulation of lipid-rich vacuoles that were stained with Oil Red O (Fig. 3E) . The intracytoplasmic Consistent with Safranin-O staining results, ferumoxides-labeled cultures, at appropriate concentration (50-ferumoxides was confirmed by PB staining (Fig. 3A and  D) in the differentiated cells.
100 µg/ml), expressed mRNA of chondrocyte proteins such as aggrecan, collagen type II (Col II), collagen type Chondrogenic Differentiation of Ferumoxides-Labeled IX (Col IX), and Sox-IX at 4 weeks; however, the ex-hUCB MSCs pression of Col IX was decreased depending on the concentration of ferumoxides (Fig. 4C ). In addition, Col II The influence of ferumoxides labeling on chondrogenic differentiation of hUCB MSC was evaluated by and Col IX were not detected, and aggrecan was very weakly detected, in 200 µg/ml ferumoxides-labeled cul-Safranin-O stain and RT-PCR. hUCB MSCs, unlabeled or labeled with ferumoxides, were centrifuged to form a tures. pellet micromass, and cultured in serum-free chondro-Neurogenic Differentiation of Ferumoxides-Labeled genic medium. After 4 weeks of differentiation, the in-hUCB MSCs tracytoplasmic ferumoxides were confirmed by PB staining (Fig. 4A) in the histological sections. The accu-Prior to evaluation of the influence on neurogenic differentiation by ferumoxides labeling, we demonstrated mulation of sulfated proteoglycans was visualized by Safranin-O staining. As shown in Figure 4B , the chon-neurogenic differentiation in the hUCB MSCs. As which are neuronal maturity markers, was increased after 6 h of neuronal induction. However, the level of mRNA for TBIII, which is known as a marker for immature neuronal cells, was not changed during the neuronal induction period (Fig. 5B ). As shown in Figure 5C , Western blot analysis showed that the expression of NeuN, which is a mature neuron marker, was increased in the neurogenic-induced MSCs. By contrast, the expression of TBIII was significantly diminished.
Influence of Ferumoxides on Neurogenic Differentiation of hUCB MSCs
The presence of intracytoplasmic ferumoxides was confirmed by PB staining (Fig. 6A ) in differentiated cells. As shown in Figure 6A , ferumoxides labeling did not prevent neuron-like differentiation at any concentration within 6 h. However, after 72 h, cells labeled with high concentrations of ferumoxides (200 µg/ml) showed shown in Figure 5A , neurogenic stimulants induced morphological changes towards neuron-like cells; this can be used as stable nanoparticles capable of in vivo cell tracking by labeling through endosomal capture. Ferumoxides are negatively charged SPIO that do not attach to the cell membrane without modification of the nanoparticle surface charges. Recently, various methods have been reported to label adult stem cells with ferumoxides. Poly-L-lycine (PLL) has been used as a labeling agent for human stem cells and other mammalian cells (1, 2) ; PLLs have been reported to be efficient agents for endosomal incorporation of magnetic particles. However, PLL-ferumoxides labeling interfered with chondrogenesis of bone marrow-derived MSC (16); cytotoxic effects with neurogenic induction. To further investigate the cytotoxic effect of ferumoxides, we performed the trypan blue dye exclusion assay. Trypan blue dye exclusion assay indicated that 200 µg/ml ferumoxides labeling decreased (50%) cell viability during neurogenic induction (Fig. 6B) . The results of the Western blot analysis showed that the expression of NeuN was decreased by labeling with 100 µg/ml ferumoxides compared with 0 ( Fig. 5C ), 25 or 50 µg/ml ferumoxides labeling (Fig. 6C) . These results imply that hUCB-MSCs can differentiate into mature neuron-like cells, and that ferumoxides labeling over 100 µg/ml can prevent neuronal differentiation. ture (3) . Ferumoxides is a US FDA-approved agent that moreover, the incubation time of PLL with ferumoxides genic differentiation method by simple chemical to demonstrate the influence of ferumoxides on neurogenic affects the size of the ferumoxides-PLL complex. Over time, incubation led to the formation of oversize parti-differentiation of hUCB MSCs. As shown in Figure 6B , neurogenic differentiation using simple chemicals did cles for incorporation into the endosomes in cells (3) . Protamine sulfate, a US FDA-approved agent, can be not induce cellular toxicity of hUCB MSCs. The reason for the varied capacity to undergo neurogenic differenti-used as a labeling agent for ferumoxides. This agent has been used to effectively label a variety of cells with no ation has not yet been reported. In this study, we noted that the number of cells per square centimeter as well as effect on cell viability, proliferation, and differentiation. Although the use of protamin sulfate has demonstrated whether cord blood was a source affecting the differentiating capacity of MSCs. For most of the hUCB MSCs, a labeling efficiency, as a translation ex vivo cell labeling method from the bench to the bedside, the best method cell density of 2,500-3,000/cm 2 resulted in reproducible neurogenic differentiation (data not shown). for ferumoxides labeling in cells is without any labeling agents. Magnetoelectroporation has been demonstrated In the research on bone marrow-derived MSCs, ferumoxides labeling using PLL (2, 10) or protamin sulfate to be an alternative method for endosomal labeling with the ferumoxides, without the need for labeling agents (3) did not show short-or long-term toxicity on multilineage differentiation. By contrast, Kostura et al. has re- (27) . With high concentration of ferumoxides used for labeling, magnetoelectroporation-labeled stem cells ex-cently reported that labeling bone marrow-derived MSCs with 25 µg/ml of ferumoxides prevented chondrogenic hibited an unaltered viability, proliferation, and mitochondrial metabolic rate. In this study, we demonstrated differentiation (16). In the present study, we found a dose-dependent reduction in chondrogenic differentia-that ferumoxides can be used to label hUCB MSCs efficiently without using other agents. The current method tion with ferumoxides labeling. At 200 µg/ml, the ferumoxides-labeled cultures had abnormal shaped lacunae; showed a very similar proliferation rate and cytotoxicity between ferumoxides-labeled and unlabeled cells. Al-these tissues did not express Col II and Col IX mRNA. Although chondrogenic differentiation was blocked by though the exact intracellular uptake mechanism for ferumoxides is not known, intracellular incorporated fer-our labeling methods, ferumoxides at a concentration of 50-100 µg/ml showed very clean labeling and a lower umoxides was clearly detected at a variety of concentrations from 25 to 200 µg/ml of fermuoxide as determined cytotoxic level than when using PLL as the labeling agent. We also found that neurogenic differentiation of by PB staining. This is in sharp contrast to experiments performed by Kostura et al. (16), who reported failure hUCB MSCs can be blocked by ferumoxides labeling. Incubation for 72 h with a high concentration (200 µg/ of ferumoxides to label MSCs without labeling agents. However, they obtained their results using a different ml) of ferumoxides resulted in increased cytotoxicity compared with controls ( Fig. 6B ). Moreover, based on source of cells, bone marrow-derived MSCs; therefore, their conclusions cannot be compared with our data.
the results of the Western blot analysis, at a concentration above 100 µg/ml ferumoxides decreased the expres-In this study, we used different hUCB MSCs for the differentiation experiments, because we had found that sion of immature and mature neuronal markers (Fig.  6C ). However, we confirmed that with the appropriate each hUCB MSC has different ability to differentiate into the adipogenic and neurogenic lineages. Bieback et concentration (25-50 µg/ml) of ferumoxides labeling showed similar differentiation in cells with neuron-like al. (4) reported that hUCB MSC-like cells were difficult to differentiate into adipocytes and required specific cul-morphology compared to unlabeled cells. These results imply that hUCB MSCs can differentiate into mature ture conditions to differentiate into an adipogenic lineage. Campagnoli et al. (8) and Goodwin et al. (14) sug-neuron-like cells, and ferumoxides labeling over 100 µg/ ml can prevent neuronal differentiation. gested that clonal cell isolation and a large number of cell doublings may have caused altered responsiveness
In conclusion, ferumoxides, without a labeling agent, effectively labeled hUCB MSCs with no or little effect in the MSC-like cells towards adipogenic induction. Moreover, the varied capacity to undergo adipogenic on cell viability and proliferation. However, the multilineage and transdifferentiation capabilities of hUCB differentiation may be explained by the fact that cord blood cells more closely resemble primitive cells, be-MSCs were partially inhibited; these inhibitions were dependent on the concentration of ferumoxides. Further cause adipocytes may increase with aging to either occupy excess or support hematopoiesis (12).
studies are needed to understand the mechanism of inhibition on differentiation. In addition, the appropriate Recent studies have indicated that morphological changes and increases in neuronal markers of bone mar-concentration of ferumoxides for clinical application must be evaluated by conducting animal studies. Cur-row-derived MSCs by simple chemicals are likely the result of cellular toxicity and do not represent neuro-rently, we cannot conclude whether labeling with ferumoxides induces a positive or negative influence on genic differentiation (21). However, we used a neuro- tion activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers. Biol. Blood
